pharma & biotech
FDA Seeks to Block Two Unregulated Stem Cell Clinics
FDA Seeks to Block Two Unregulated Stem Cell Clinics
Jim Daley | May 11, 2018
Two patients became legally blind after receiving treatments at the facilities.
Novartis Paid More than $1 Million to Firm Linked to Trump Lawyer
Novartis Paid More than $1 Million to Firm Linked to Trump Lawyer
Ashley Yeager | May 9, 2018
The drug company had an agreement with Essential Consultants, run by the president’s former attorney Michael Cohen.
CRISPR Patent Dispute Heard in Federal Court
CRISPR Patent Dispute Heard in Federal Court
Jim Daley | May 1, 2018
In an ongoing legal battle, the University of California, Berkeley has challenged the Broad Institute’s patent claims on the gene editing technology.
How Orphan Drugs Became a Highly Profitable Industry
How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.
Women Less Successful When Applying for Patents
Women Less Successful When Applying for Patents
Diana Kwon | Apr 18, 2018
An investigation of 2.7 million patent submissions in the U.S. finds gender disparities throughout the application process.
First Blood Test for Concussion Approved by FDA
First Blood Test for Concussion Approved by FDA
Kerry Grens | Feb 16, 2018
The diagnostic measures two proteins indicative of brain injury.
Former Head of Genzyme Dies
Former Head of Genzyme Dies
Diana Kwon | May 15, 2017
Henri Termeer helped usher the biotech company into an industry behemoth.
Direct-to-Consumer Liquid Biopsy
Direct-to-Consumer Liquid Biopsy
Kerry Grens | Sep 13, 2015
Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.
Venter’s New Digs
Venter’s New Digs
Bob Grant | Oct 9, 2013
Genomics pioneer Craig Venter is building a new campus for his non-profit research institute right next to his alma mater in San Diego.